Yes, but first, as I have always advocated here many years ago, RAP should have tried to roll out its product in Australia first. Like that other company with a truly experienced CEO. I hear that company is now starting to go global after all nicks and kicks were ironed out in the domestic market.
This company instead screamed at the top of TK's lung that they are going to get FDA approval and then it will be $10/cough. They even employed a company with 99.99% success rate with FDA only for them to achieve that 0.001% failure rate for RAP. And as they say, the rest is history.
